Tiziana Life Sciences Ltd (STU:0RP) Stock News, Headlines & Updates
Tiziana Life Sciences Ltd Stock News from GuruFocus
- 1
Jun 11, 2024
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
Marketwired • 7:00am
Jun 06, 2024
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
Marketwired • 8:00am
Jun 04, 2024
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
Marketwired • 8:00am
May 30, 2024
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
Marketwired • 6:00am
May 13, 2024
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
Marketwired • 6:00am
Apr 25, 2024
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
Marketwired • 9:00am
Apr 23, 2024
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
Marketwired • 6:00am
Apr 22, 2024
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
Marketwired • 6:00am
Apr 19, 2024
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
Marketwired • 6:00am
Apr 18, 2024
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
Marketwired • 6:00am
Apr 11, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news